These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8511078)

  • 1. [Gallium-67 scintigraphy in malignant lymphoma].
    Cohen-Haguenauer O; Brice P; Gaci M; Le Pailleur A; Cheval E; Bris C; Frija J; Gisselbrecht C; Rain JD; Najean Y
    Presse Med; 1993 Mar; 22(11):521-5. PubMed ID: 8511078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [False-positive findings of 67-gallium scintigraphy in staging/restaging of malignant lymphoma].
    Bihl H; Kimmig B
    Rofo; 1987 Feb; 146(2):172-7. PubMed ID: 3029830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of flow cytometric parameters and transferrin receptors with gallium-67 scintigraphic images in lymphoma patients.
    Kiratli PO; Canpinar H; Ruacan S; Kansu E
    Nucl Med Commun; 2000 Oct; 21(10):925-31. PubMed ID: 11130333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma.
    Rehm PK
    Cancer Biother Radiopharm; 1999 Aug; 14(4):251-62. PubMed ID: 10850311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
    Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
    Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of residual masses after lymphoma treatment: the contribution of gallium 67 tomoscintigraphy.
    Nedellec G; Lioure B; Bussy E; de Revel T; Carlioz R; Gaillard JF; Auzanneau G
    Nouv Rev Fr Hematol (1978); 1990; 32(3):187-90. PubMed ID: 2216703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium-67-citrate scanning for the localization and staging of lymphomas.
    Adler S; Parthasarathy KL; Bakshi SP; Stutzman L
    J Nucl Med; 1975 Apr; 16(4):255-60. PubMed ID: 1089769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
    Brice P; Rain JD; Frija J; Miaux Y; Marolleau JP; Tredaniel J; Ferme C; Hennequin C; Gisselbrecht C
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):457-61. PubMed ID: 8414967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
    Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
    Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography scanning in the assessment of patients with lymphoma.
    Foo SS; Mitchell PL; Berlangieri SU; Smith CL; Scott AM
    Intern Med J; 2004 Jul; 34(7):388-97. PubMed ID: 15271172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of Ga-67 SPECT in patients with malignant lymphoma after primary chemotherapy for further treatment planning: comparison with spiral CT].
    Stroszczynski C; Amthauer H; Hosten N; Mapara M; Ricke J; Jochens R; Fischer-Funk E; Ludwig WD; Eichstädt H; Felix R
    Rofo; 1997 Nov; 167(5):458-66. PubMed ID: 9440890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomas.
    Turner DA; Fordham EW; Ali A; Slayton RE
    Semin Nucl Med; 1978 Jul; 8(3):205-18. PubMed ID: 715464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
    Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
    Sarda L; Duet M; Zini JM; Berolatti B; Benelhadj S; Tobelem G; Mundler O
    Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical staging and diagnosis of malignant lymphoma].
    Niibe H; Tamaki Y; Akimoto T
    Gan No Rinsho; 1988 Apr; 34(5):541-54. PubMed ID: 3164415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.